Institutional investors hold a majority ownership of CBST through the 106.56% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2014, these large investors purchased a net $1.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
POINTSTATE CAPITAL LP Bought 930.0 Thousand shares of Cubist Pharmaceuticals In...